2016 13 Jun
Masimo (NASDAQ: MASI) has announced FDA 510(k) clearance for O3™ regional oximetry. Regional oximetry, also referred to as tissue or cerebral oximetry, may help clinicians monitor cerebral oxygenation in situations in which pulse oximetry alone may not be fully indicative of the oxygen in the brain due to various factors, such as the type of clinical... Read more
JOIN OUR MANAGEMENT COMMUNITY
Controlling Pain with Ultrasound-Guided Regional Anaesthesia
The scope of ultrasound-guided regional anaesthesia has grown significantly in... Read more
Dubai Health Authority Implements Masimo Patient SafetyNet™
Masimo (NASDAQ:MASI) announced today that the Dubai Health Authority&n Read more
UPMC, considers opportunities to join Moscow International Medical Cluster
UPMC, world-renowned health care provider from USA, arrived on official... Read more
Philips Speeds Up Research and Biomarker Discovery with Major Upgrade
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health techno... Read more
Clinical Trials Demonstrate Benefits of iFR Compared to FFR
The DEFINE FLAIR and iFR Swedeheart studies establish that iFR offers a... Read more
Geraldine McGinty Appointed Chief Strategy Officer, Weill Cornell Medicine Physician Organization
Dr. Geraldine McGinty has been named Chief Strategy Officer for the Weill... Read more
EOS imaging Appoints Mike Lobinsky to Newly Created Position of President, North America
Proven executive experienced in orthopedics and medical imaging will lead... Read more
John Ormiston Awarded the EuroPCR 2017 Ethica Award
The 2017 Ethica Award, the highest honour of the European cardiovascular... Read more
Primex Pharmaceuticals Appoints Jostein Davidsen and Angelo Colombo as Board Members
Swiss pharmaceutical group Primex Pharmaceuticals AG announces new board... Read more
New President of Sectra’s Secure Communications Business Area
Simo Pykälistö, currently CFO and Executive Vice President of Sectra AB... Read more
JOIN OUR MANAGEMENT COMMUNITY
JOIN OUR MANAGEMENT COMMUNITY